KYORIN Holdings, Inc. (4569.T) JPX

Currency In JPY

Key Executives

Name	Title	Year Born
Yutaka Ogihara	President, Chief Executive Officer & Chairman	1967
Kiyoo Uehara	Managing Executive Officer, CHRO & General Affairs Manager	N/A
Junichi Ishiyama	Managing Executive Officer, CSO & Head of Drug Discovery Div.	N/A
Kenichi Nakamura	Corporate Officer & President of KYORIN Pharmaceutical Group Facilities Co., Ltd.	N/A
Michiro Onota	Exe. Director, Mng. Corp. Off., CMO, Chairman of KYORIN Pharmaceutical Grp. Facilities Co., Ltd	1960
Noriaki Tamura	Managing Executive Officer, Chief Commercial Officer & GM of Pharmaceutical Sales Division	N/A
Yasuji Kurose	CFO, CSO, Managing Executive Officer, Director of Corporate Planning & Executive Director	1970
Takaaki Kaji	Senior Managing Executive Officer & Chief Business Development Officer	N/A

Name

Title

Pay

Year Born

Yutaka Ogihara

President, Chief Executive Officer & Chairman

1967

Kiyoo Uehara

Managing Executive Officer, CHRO & General Affairs Manager

N/A

Junichi Ishiyama

Managing Executive Officer, CSO & Head of Drug Discovery Div.

N/A

Kenichi Nakamura

Corporate Officer & President of KYORIN Pharmaceutical Group Facilities Co., Ltd.

N/A

Michiro Onota

Exe. Director, Mng. Corp. Off., CMO, Chairman of KYORIN Pharmaceutical Grp. Facilities Co., Ltd

1960

Noriaki Tamura

Managing Executive Officer, Chief Commercial Officer & GM of Pharmaceutical Sales Division

N/A

Yasuji Kurose

CFO, CSO, Managing Executive Officer, Director of Corporate Planning & Executive Director

1970

Takaaki Kaji

Senior Managing Executive Officer & Chief Business Development Officer

N/A

Description

Based in Tokyo, Japan, and founded in 1923, KYORIN Holdings, Inc. is a pharmaceutical enterprise engaged in the discovery, development, production, and worldwide distribution of both innovative prescription drugs and generic equivalents. Its diverse therapeutic catalog features medications such as Flutiform for asthma; Desalex, an antiallergic agent; and treatments like Beova, Uritos, and Imidafenacin KYORIN for overactive bladder. The company also offers Lasvic, a quinolone antibacterial; Pentasa for managing ulcerative colitis and Crohn's disease; Nasonex and Kipres for allergic rhinitis; and Mucodyne, a mucoregulating compound. Further pharmaceutical products include Montelukast KM, prescribed for bronchial asthma and allergic rhinitis. Beyond drugs, KYORIN Holdings markets specialized items like the GeneSoC real-time PCR system, disinfectant solutions such as Rubysta and Milton, over-the-counter remedies, diagnostic tools, industrial chemicals, and various reagents and intermediates. The company extends its services to include contract drug manufacturing and actively participates in early-stage research, including identifying and assessing candidate compounds, analyzing competitor technologies, and collecting data from clinical trials.